H-Index
79
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
15%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
AmJCaseRep

Annals
ISI-Home

eISSN: 1643-3750

Effects of Rosuvastatin and MiR-126 on Myocardial Injury Induced by Acute Myocardial Infarction in Rats: Role of Vascular Endothelial Growth Factor A (VEGF-A)

Ling Fei, Jun Zhang, Heping Niu, Chen Yuan, Xiaoli Ma

Fifth Department of Cardiology, Cangzhou Central Hospital, Cangzhou, Hebei, China (mainland)

Med Sci Monit 2016; 22:2324-2334

DOI: 10.12659/MSM.896983

Available online:

Published: 2016-07-04


#896983

BACKGROUND: The present study investigated the effects of VEGF-A targeted by miR-126 on myocardial injury after acute myocardial infarction (AMI) in rats, along with the contributions of rosuvastatin to the synergic effect.
MATERIAL AND METHODS: SD rats were obtained to construct AMI models by ligating their left anterior descending coronary arteries (LAD). We conducted echocardiography to check the 6 involved indexes: left ventricular ejection fractions (LVEF), fractional shortening (FS), left ventricular end-systolic volume (LVV), left ventricular end-diastolic volume (LVVd), cardiac output (CO), and heart rate (HR). Moreover, antibody sandwich enzyme-linked immunosorbent assay was carried out to determine MI markers: creatine kinase (CK), CK Isoenzyme (CK-MB), and Troponin I (cTn I). Dual-Luciferase Reporter Assay was performed to confirm the targeting of miR-126 and VEGF-A. MTT assay provided insight into the proliferation of myocardial fibroblasts. Finally, RT-RCR and Western blot were used for the detection of miR-126 and VEGF-A expressions in vivo and in vitro.
RESULTS: Luciferase activity assay showed that miR-126 transfection significantly decreased the relative luciferase activity in HEK293T cells when it was bound to normal 3’ UTR of VEGF-A (P<0.05). In comparison to the control group, rats in the AMI model group had significantly lower LVEF, FS, and CO, and substantially higher LVVs, LVVd, HR, CK/U, CK-MB/U, and cTn-1/U (all P<0.05). Down-regulated miR-126 and up-regulated VEGF-A were also observed in MI models (P<0.05).
CONCLUSIONS: miR-126 and rosuvastatin have protective effects on AMI risk, and VEGF-A antagonizes effects on AMI is imposed by.

Keywords: Biomarkers - metabolism, Animals, Creatine Kinase, MB Form - metabolism, Disease Models, Animal, HEK293 Cells, Heart Injuries, MicroRNAs - metabolism, Myocardial Infarction - pathology, Myocardium - metabolism, Random Allocation, Rats, Rats, Sprague-Dawley, Rosuvastatin Calcium - pharmacology, Stroke Volume - physiology, Transfection, Vascular Endothelial Growth Factor A - metabolism, Ventricular Function, Left - physiology



Back